檢索結果 - Demos, Maria

Ixazomib, dexamethasone, and rituximab in treatment-naive patients with Waldenström macroglobulinemia: long-term follow-up 由 Castillo, Jorge J., Meid, Kirsten, Flynn, Catherine A., Chen, Jiaji, Demos, Maria G., Guerrera, Maria L., Kofides, Amanda, Liu, Xia, Munshi, Manit, Tsakmaklis, Nicholas, Patterson, Christopher J., Yang, Guang, Hunter, Zachary, Treon, Steven P.

獲取全文 獲取全文 獲取全文

Genomic Evolution of Ibrutinib Resistant Clones in Waldenström Macroglobulinemia 由 Jiménez, Cristina, Chan, Gloria G., Xu, Lian, Tsakmaklis, Nickolas, Kofides, Amanda, Demos, Maria G., Chen, Jiaji, Liu, Xia, Munshi, Manit, Yang, Guang, Castillo, Jorge J., Wiestner, Adrian, García- Sanz, Ramón, Treon, Steven P., Hunter, Zachary R.

獲取全文 獲取全文 獲取全文

Comparative genomics of CXCR4(MUT) and CXCR4(WT) single cells in Waldenström’s macroglobulinemia 由 Jiménez, Cristina, Xu, Lian, Tsakmaklis, Nickolas, Demos, Maria G., Kofides, Amanda, Chan, Gloria G., Guerrera, Maria Luisa, Chen, Jiaji G., Liu, Xia, Munshi, Manit, Patterson, Christopher J., Yang, Guang, Castillo, Jorge J., Treon, Steven P., Hunter, Zachary R.

獲取全文 獲取全文 獲取全文

Bone marrow involvement and subclonal diversity impairs detection of mutated CXCR4 by diagnostic next generation sequencing in Waldenström macroglobulinemia 由 Gustine, Joshua N., Xu, Lian, Yang, Guang, Liu, Xia, Kofides, Amanda, Tsakmaklis, Nicholas, Munshi, Manit, Demos, Maria, Guerrera, Maria Luisa, Meid, Kirsten, Patterson, Christopher J., Sarosiek, Shayna, Branagan, Andrew R., Hunter, Zachary R., Castillo, Jorge J., Treon, Steven P.

獲取全文 獲取全文 獲取全文

Response and Survival Outcomes to Ibrutinib Monotherapy for Patients With Waldenström Macroglobulinemia on and off Clinical Trials 由 Castillo, Jorge J., Gustine, Joshua N., Meid, Kirsten, Flynn, Catherine A., Demos, Maria G., Guerrera, Maria L., Jimenez, Cristina, Kofides, Amanda, Liu, Xia, Munshi, Manit, Tsakmaklis, Nicholas, Patterson, Christopher J., Xu, Lian, Yang, Guang, Hunter, Zachary R., Treon, Steven P.

獲取全文 獲取全文 獲取全文

Acquired mutations associated with ibrutinib resistance in Waldenström macroglobulinemia 由 Xu, Lian, Tsakmaklis, Nicholas, Yang, Guang, Chen, Jiaji G., Liu, Xia, Demos, Maria, Kofides, Amanda, Patterson, Christopher J., Meid, Kirsten, Gustine, Joshua, Dubeau, Toni, Palomba, M. Lia, Advani, Ranjana, Castillo, Jorge J., Furman, Richard R., Hunter, Zachary R., Treon, Steven P.

獲取全文 獲取全文 獲取全文

Expression of the prosurvival kinase HCK requires PAX5 and mutated MYD88 signaling in MYD88-driven B-cell lymphomas 由 Liu, Xia, Chen, Jiaji G., Munshi, Manit, Hunter, Zachary R., Xu, Lian, Kofides, Amanda, Tsakmaklis, Nickolas, Demos, Maria G., Guerrera, Maria Luisa, Chan, Gloria G., Jimenez, Cristina, Patterson, Christopher J., Meid, Kirsten, Keezer, Andrew, Castillo, Jorge J., Treon, Steven P., Yang, Guang

獲取全文 獲取全文 獲取全文

CXCR4(S338X) clonality is an important determinant of ibrutinib outcomes in patients with Waldenström macroglobulinemia 由 Gustine, Joshua N., Xu, Lian, Tsakmaklis, Nicholas, Demos, Maria G., Kofides, Amanda, Chen, Jiaji G., Liu, Xia, Munshi, Manit, Guerrera, Maria Luisa, Chan, Gloria G., Patterson, Christopher J., Keezer, Andrew, Meid, Kirsten, Dubeau, Toni, Yang, Guang, Hunter, Zachary R., Treon, Steven P., Castillo, Jorge J.

獲取全文 獲取全文 獲取全文

Natural history of Waldenström macroglobulinemia following acquired resistance to ibrutinib monotherapy 由 Gustine, Joshua N., Sarosiek, Shayna, Flynn, Catherine A., Meid, Kirsten, Leventoff, Carly, White, Timothy, Guerrera, Maria Luisa, Xu, Lian, Kofides, Amanda, Tsakmaklis, Nicholas, Munshi, Manit, Demos, Maria, Patterson, Christopher J., Liu, Xia, Yang, Guang, Hunter, Zachary R., Branagan, Andrew R., Treon, Steven P., Castillo, Jorge J.

獲取全文 獲取全文 獲取全文

Insights into the genomic landscape of MYD88 wild-type Waldenström macroglobulinemia 由 Hunter, Zachary R., Xu, Lian, Tsakmaklis, Nickolas, Demos, Maria G., Kofides, Amanda, Jimenez, Cristina, Chan, Gloria G., Chen, Jiaji, Liu, Xia, Munshi, Manit, Gustine, Joshua, Meid, Kirsten, Patterson, Christopher J., Yang, Guang, Dubeau, Toni, Samur, Mehmet K., Castillo, Jorge J., Anderson, Kenneth C., Munshi, Nikhil C., Treon, Steven P.

獲取全文 獲取全文 獲取全文

Human MYD88(L265P) is insufficient by itself to drive neoplastic transformation in mature mouse B cells 由 Sewastianik, Tomasz, Guerrera, Maria Luisa, Adler, Keith, Dennis, Peter S., Wright, Kyle, Shanmugam, Vignesh, Huang, Ying, Tanton, Helen, Jiang, Meng, Kofides, Amanda, Demos, Maria G., Dalgarno, Audrey, Patel, Neil A., Nag, Anwesha, Pinkus, Geraldine S., Yang, Guang, Hunter, Zachary R., Jarolim, Petr, Munshi, Nikhil C., Treon, Steven P., Carrasco, Ruben D.

獲取全文 獲取全文 獲取全文

Diagnostic Next-generation Sequencing Frequently Fails to Detect MYD88(L265P) in Waldenström Macroglobulinemia 由 Kofides, Amanda, Hunter, Zachary R., Xu, Lian, Tsakmaklis, Nicholas, Demos, Maria G., Munshi, Manit, Liu, Xia, Guerrera, Maria Luisa, Leventoff, Carly R., White, Timothy P., Flynn, Catherine A., Meid, Kirsten, Patterson, Christopher J., Yang, Guang, Branagan, Andrew R., Sarosiek, Shayna, Castillo, Jorge J., Treon, Steven P., Gustine, Joshua N.

獲取全文 獲取全文 獲取全文

MYD88 mutated and wild-type Waldenström’s Macroglobulinemia: characterization of chromosome 6q gene losses and their mutual exclusivity with mutations in CXCR4 由 Guerrera, Maria Luisa, Tsakmaklis, Nickolas, Xu, Lian, Yang, Guang, Demos, Maria, Kofides, Amanda, Chan, Gloria G., Manning, Robert J., Liu, Xia, Chen, Jiaji G., Munshi, Manit, Patterson, Christopher J., Castillo, Jorge J., Dubeau, Toni, Gustine, Joshua, Carrasco, Ruben D., Arcaini, Luca, Varettoni, Marzia, Cazzola, Mario, Treon, Steven P., Hunter, Zachary R.

獲取全文 獲取全文 獲取全文

The HCK/BTK inhibitor KIN-8194 is active in MYD88-driven lymphomas and overcomes mutated BTK(Cys481) ibrutinib resistance 由 Yang, Guang, Wang, Jinhua, Tan, Li, Munshi, Manit, Liu, Xia, Kofides, Amanda, Chen, Jiaji G., Tsakmaklis, Nicholas, Demos, Maria G., Guerrera, Maria Luisa, Xu, Lian, Hunter, Zachary R., Che, Jinwei, Patterson, Christopher J., Meid, Kirsten, Castillo, Jorge J., Munshi, Nikhil C., Anderson, Kenneth C., Cameron, Michael, Buhrlage, Sara J., Gray, Nathanael S., Treon, Steven P.

獲取全文 獲取全文 獲取全文

Long-term follow-up of ibrutinib monotherapy in treatment-naive patients with Waldenstrom macroglobulinemia 由 Castillo, Jorge J., Meid, Kirsten, Gustine, Joshua N., Leventoff, Carly, White, Timothy, Flynn, Catherine A., Sarosiek, Shayna, Demos, Maria G., Guerrera, Maria L., Kofides, Amanda, Liu, Xia, Munshi, Manit, Tsakmaklis, Nicholas, Xu, Lian, Yang, Guang, Branagan, Andrew R., O’Donnell, Elizabeth, Raje, Noopur, Yee, Andrew J., Patterson, Christopher J., Hunter, Zachary R., Treon, Steven P.

獲取全文 獲取全文 獲取全文

Partial response or better at 6 months is prognostic of superior progression-free survival in Waldenstrom macroglobulinemia patients treated with ibrutinib 由 Castillo, Jorge J., Abeykoon, Jithma P., Gustine, Joshua N., Zanwar, Saurabh, Mein, Kirsten, Flynn, Catherine A., Demos, Maria G., Guerrera, Maria L., Kofides, Amanda, Liu, Xia, Munshi, Manit, Tsakmaklis, Nickolas, King, Rebecca, Yang, Guang, Hunter, Zachary R., Advani, Ranjana H., Palomba, M. Lia, Ansell, Stephen M., Gertz, Morie A., Kapoor, Prashant, Treon, Steven P.

獲取全文 獲取全文 獲取全文

SYK is activated by mutated MYD88 and drives pro-survival signaling in MYD88 driven B-cell lymphomas 由 Munshi, Manit, Liu, Xia, Chen, Jiaji G., Xu, Lian, Tsakmaklis, Nickolas, Demos, Maria G., Kofides, Amanda, Guerrera, Maria Luisa, Jimenez, Cristina, Chan, Gloria G., Hunter, Zachary R., Palomba, M. Lia, Argyropoulos, Kimon V., Meid, Kirsten, Keezer, Andrew, Gustine, Joshua, Dubeau, Toni, Castillo, Jorge J., Patterson, Christopher J., Wang, Jinhua, Buhrlage, Sara J., Gray, Nathanael S., Treon, Steven P., Yang, Guang

獲取全文 獲取全文 獲取全文

Genomic Landscape of Waldenström Macroglobulinemia and Its Impact on Treatment Strategies 由 Treon, Steven P., Xu, Lian, Guerrera, Maria Luisa, Jimenez, Cristina, Hunter, Zachary R., Liu, Xia, Demos, Maria, Gustine, Joshua, Chan, Gloria, Munshi, Manit, Tsakmaklis, Nicholas, Chen, Jiaji G., Kofides, Amanda, Sklavenitis-Pistofidis, Romanos, Bustoros, Mark, Keezer, Andrew, Meid, Kirsten, Patterson, Christopher J., Sacco, Antonio, Roccaro, Aldo, Branagan, Andrew R., Yang, Guang, Ghobrial, Irene M., Castillo, Jorge J.

獲取全文 獲取全文 獲取全文

Venetoclax in Previously Treated Waldenström Macroglobulinemia 由 Castillo, Jorge J., Allan, John N., Siddiqi, Tanya, Advani, Ranjana H., Meid, Kirsten, Leventoff, Carly, White, Timothy P., Flynn, Catherine A., Sarosiek, Shayna, Branagan, Andrew R., Demos, Maria G., Guerrera, Maria L., Kofides, Amanda, Liu, Xia, Munshi, Manit, Tsakmaklis, Nicholas, Xu, Lian, Yang, Guang, Patterson, Christopher J., Hunter, Zachary R., Davids, Matthew S., Furman, Richard R., Treon, Steven P.

獲取全文 獲取全文 獲取全文

Phase 1 study of ibrutinib and the CXCR4 antagonist ulocuplumab in CXCR4-mutated Waldenström macroglobulinemia 由 Treon, Steven P., Meid, Kirsten, Hunter, Zachary R., Flynn, Catherine A., Sarosiek, Shayna R., Leventoff, Carly R., White, Timothy P., Cao, Yang, Roccaro, Aldo M., Sacco, Antonio, Demos, Maria G., Guerrera, Maria Luisa, Kofides, Amanda, Liu, Xia, Xu, Lian, Patterson, Christopher J., Munshi, Manit, Tsakmaklis, Nicholas, Yang, Guang, Ghobrial, Irene M., Branagan, Andrew R., Castillo, Jorge J.

獲取全文 獲取全文 獲取全文